HUEY-LING CHENYEN-HSUAN NIPEI-JER CHENMEI-HWEI CHANG2020-03-102020-03-1020190168-8278https://www.scopus.com/inward/record.uri?eid=2-s2.0-85074664577&doi=10.1016%2fj.jhep.2019.07.023&partnerID=40&md5=050cbdcd55664305236771f5b25ae548https://scholars.lib.ntu.edu.tw/handle/123456789/475048English[SDGs]SDG3alanine aminotransferase; hepatitis B surface antigen; interferon; lamivudine; antivirus agent; hepatitis B surface antigen; alanine aminotransferase blood level; antiviral therapy; chronicity; clinical article; disease clearance; hepatitis B; human; immunological tolerance; infant; Letter; pediatric patient; practice guideline; priority journal; seroconversion; hepatitis B; Antiviral Agents; Hepatitis B; Hepatitis B Surface Antigens; Humansletter10.1016/j.jhep.2019.07.023315822672-s2.0-85074664577